EcoDrugPlus

Akt Serine/threonine Kinase 1

Ensembl ID : ENSOJAG00000020610
Gene Symbol: AKT1
1 Cross references
195 Possible Orthologues:

Apex Nuclease (Multifunctional Dna Repair Enzyme) 1

Ensembl ID : ENSOJAG00000008491
Gene Symbol: APEX1
1 Cross references
212 Possible Orthologues:

Aph1b Gamma Secretase Subunit

Ensembl ID : ENSOJAG00000000118
Gene Symbol: APH1B
1 Cross references
190 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 1

Ensembl ID : ENSOJAG00000020335
Gene Symbol: ABCC1
1 Cross references
201 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1a, Tandem Duplicate 2

Ensembl ID : ENSOJAG00000012725
Gene Symbol: ATP1A1A.2
1 Cross references
181 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 2a

Ensembl ID : ENSOJAG00000005506
Gene Symbol: ATP1A2A
1 Cross references
205 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSOJAG00000000760
Gene Symbol: ATP1B1
1 Cross references
225 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1b

Ensembl ID : ENSOJAG00000017578
Gene Symbol: ATP1B1B
1 Cross references
220 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSOJAG00000015295
Gene Symbol: ATP1B2
1 Cross references
200 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2b

Ensembl ID : ENSOJAG00000023967
Gene Symbol: ATP1B2B
1 Cross references
203 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3b

Ensembl ID : ENSOJAG00000016472
Gene Symbol: ATP1B3B
1 Cross references
232 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSOJAG00000009489
Gene Symbol: AXL
1 Cross references
187 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).